 Stephanie Bryant
Concepts (332)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 86 | 2024 | 637 | 17.570 |
Why?
| | Polyethylene Glycols | 67 | 2024 | 601 | 14.510 |
Why?
| | Chondrocytes | 37 | 2023 | 203 | 10.930 |
Why?
| | Tissue Engineering | 52 | 2024 | 391 | 10.440 |
Why?
| | Cartilage | 26 | 2023 | 181 | 6.250 |
Why?
| | Biocompatible Materials | 28 | 2023 | 395 | 4.720 |
Why?
| | Extracellular Matrix | 29 | 2023 | 500 | 4.050 |
Why?
| | Tissue Scaffolds | 18 | 2024 | 197 | 3.890 |
Why?
| | Osteogenesis | 10 | 2023 | 197 | 3.220 |
Why?
| | Cattle | 39 | 2023 | 981 | 3.010 |
Why?
| | Chondrogenesis | 9 | 2021 | 82 | 2.870 |
Why?
| | Biomimetic Materials | 8 | 2019 | 72 | 2.570 |
Why?
| | Foreign-Body Reaction | 6 | 2024 | 26 | 2.490 |
Why?
| | Matrix Metalloproteinases | 6 | 2020 | 92 | 2.370 |
Why?
| | Cartilage, Articular | 11 | 2024 | 297 | 2.180 |
Why?
| | Macrophages | 11 | 2024 | 1482 | 2.080 |
Why?
| | Cell Culture Techniques | 11 | 2022 | 352 | 2.050 |
Why?
| | Cross-Linking Reagents | 12 | 2020 | 205 | 1.970 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 8 | 2014 | 74 | 1.930 |
Why?
| | Cells, Cultured | 33 | 2020 | 4106 | 1.850 |
Why?
| | Macrophage Activation | 6 | 2022 | 187 | 1.810 |
Why?
| | Enzymes | 4 | 2016 | 65 | 1.770 |
Why?
| | Click Chemistry | 4 | 2018 | 48 | 1.740 |
Why?
| | Compressive Strength | 10 | 2021 | 71 | 1.690 |
Why?
| | Stress, Mechanical | 15 | 2021 | 470 | 1.570 |
Why?
| | Bone Morphogenetic Protein 2 | 3 | 2023 | 77 | 1.560 |
Why?
| | Chondroitin Sulfates | 5 | 2018 | 34 | 1.550 |
Why?
| | Animals | 77 | 2024 | 35076 | 1.530 |
Why?
| | Dinoprostone | 3 | 2022 | 189 | 1.520 |
Why?
| | Osteocytes | 2 | 2022 | 27 | 1.500 |
Why?
| | Proteoglycans | 7 | 2019 | 110 | 1.410 |
Why?
| | Cells, Immobilized | 8 | 2019 | 21 | 1.390 |
Why?
| | Collagen | 12 | 2019 | 437 | 1.360 |
Why?
| | Cartilage Diseases | 3 | 2019 | 39 | 1.320 |
Why?
| | Sulfhydryl Compounds | 5 | 2023 | 190 | 1.300 |
Why?
| | Light | 7 | 2020 | 356 | 1.290 |
Why?
| | Mechanical Phenomena | 5 | 2019 | 82 | 1.280 |
Why?
| | Absorbable Implants | 4 | 2014 | 36 | 1.220 |
Why?
| | Peptides | 5 | 2018 | 917 | 1.200 |
Why?
| | Cell Differentiation | 11 | 2023 | 1896 | 1.130 |
Why?
| | Hyaluronic Acid | 4 | 2022 | 214 | 1.130 |
Why?
| | Osteoblasts | 2 | 2018 | 128 | 1.110 |
Why?
| | Implants, Experimental | 3 | 2019 | 18 | 1.100 |
Why?
| | Polymers | 8 | 2022 | 476 | 1.090 |
Why?
| | Extracellular Matrix Proteins | 5 | 2011 | 146 | 1.080 |
Why?
| | Glycosaminoglycans | 9 | 2019 | 85 | 1.070 |
Why?
| | Printing, Three-Dimensional | 5 | 2024 | 85 | 1.000 |
Why?
| | Aggrecans | 4 | 2014 | 14 | 1.000 |
Why?
| | Oligopeptides | 6 | 2018 | 258 | 0.990 |
Why?
| | Gene Expression Regulation | 11 | 2019 | 2549 | 0.890 |
Why?
| | Durapatite | 3 | 2023 | 35 | 0.880 |
Why?
| | Cell Survival | 9 | 2018 | 1098 | 0.880 |
Why?
| | Growth Differentiation Factor 2 | 1 | 2023 | 2 | 0.870 |
Why?
| | Proteomics | 2 | 2024 | 1008 | 0.850 |
Why?
| | Mechanotransduction, Cellular | 5 | 2016 | 111 | 0.810 |
Why?
| | Stereolithography | 2 | 2021 | 8 | 0.780 |
Why?
| | Endopeptidases | 3 | 2017 | 85 | 0.780 |
Why?
| | Esters | 1 | 2022 | 74 | 0.770 |
Why?
| | Materials Testing | 11 | 2016 | 346 | 0.770 |
Why?
| | Stromal Cells | 2 | 2012 | 107 | 0.740 |
Why?
| | Photochemistry | 5 | 2017 | 132 | 0.740 |
Why?
| | Biomimetics | 1 | 2021 | 40 | 0.740 |
Why?
| | Photochemical Processes | 3 | 2017 | 102 | 0.710 |
Why?
| | Mice | 23 | 2024 | 16832 | 0.710 |
Why?
| | Polymerization | 6 | 2021 | 125 | 0.700 |
Why?
| | Foreign Bodies | 1 | 2022 | 104 | 0.700 |
Why?
| | Tensile Strength | 3 | 2018 | 97 | 0.690 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2020 | 6 | 0.680 |
Why?
| | Nucleic Acids | 1 | 2021 | 61 | 0.680 |
Why?
| | Tendons | 2 | 2018 | 127 | 0.660 |
Why?
| | Lipopolysaccharides | 5 | 2020 | 884 | 0.650 |
Why?
| | Hyaline Cartilage | 1 | 2019 | 4 | 0.640 |
Why?
| | Transforming Growth Factor beta3 | 1 | 2019 | 8 | 0.640 |
Why?
| | Cell Adhesion | 7 | 2018 | 454 | 0.630 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2019 | 101 | 0.620 |
Why?
| | Tenocytes | 1 | 2018 | 1 | 0.600 |
Why?
| | Porosity | 6 | 2017 | 94 | 0.600 |
Why?
| | Lipid Bilayers | 1 | 2019 | 97 | 0.600 |
Why?
| | Regeneration | 4 | 2023 | 179 | 0.590 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2018 | 26 | 0.590 |
Why?
| | Secretory Pathway | 1 | 2017 | 7 | 0.560 |
Why?
| | Metal Nanoparticles | 1 | 2018 | 82 | 0.560 |
Why?
| | Protein Array Analysis | 1 | 2017 | 56 | 0.560 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 465 | 0.560 |
Why?
| | Optical Imaging | 1 | 2017 | 56 | 0.550 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 223 | 0.540 |
Why?
| | Myoblasts | 3 | 2013 | 80 | 0.540 |
Why?
| | Sepharose | 2 | 2017 | 33 | 0.520 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 56 | 0.510 |
Why?
| | Wound Healing | 2 | 2018 | 312 | 0.510 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 138 | 0.500 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2016 | 121 | 0.500 |
Why?
| | Biomechanical Phenomena | 5 | 2019 | 786 | 0.500 |
Why?
| | Weight-Bearing | 5 | 2009 | 184 | 0.490 |
Why?
| | Human Embryonic Stem Cells | 1 | 2015 | 23 | 0.480 |
Why?
| | Mice, Inbred C57BL | 9 | 2022 | 5365 | 0.470 |
Why?
| | Methacrylates | 3 | 2014 | 112 | 0.470 |
Why?
| | Elastic Modulus | 5 | 2018 | 123 | 0.460 |
Why?
| | Intracellular Fluid | 1 | 2014 | 27 | 0.460 |
Why?
| | Ions | 1 | 2014 | 67 | 0.460 |
Why?
| | Proteins | 2 | 2024 | 948 | 0.450 |
Why?
| | Osmolar Concentration | 5 | 2014 | 166 | 0.450 |
Why?
| | Immunomodulation | 1 | 2014 | 92 | 0.440 |
Why?
| | Precision Medicine | 1 | 2017 | 388 | 0.430 |
Why?
| | DNA | 5 | 2021 | 1412 | 0.430 |
Why?
| | Gene Expression | 4 | 2022 | 1487 | 0.430 |
Why?
| | Bone Marrow Cells | 2 | 2011 | 300 | 0.420 |
Why?
| | Bioreactors | 2 | 2013 | 44 | 0.420 |
Why?
| | Proteome | 1 | 2017 | 433 | 0.410 |
Why?
| | Inflammation | 2 | 2024 | 2721 | 0.410 |
Why?
| | Pancreas | 1 | 2015 | 309 | 0.410 |
Why?
| | Models, Biological | 5 | 2014 | 1716 | 0.400 |
Why?
| | Stem Cells | 2 | 2017 | 585 | 0.390 |
Why?
| | Free Radicals | 1 | 2012 | 104 | 0.390 |
Why?
| | Lactic Acid | 2 | 2011 | 296 | 0.380 |
Why?
| | Viscoelastic Substances | 1 | 2011 | 11 | 0.380 |
Why?
| | 3T3 Cells | 4 | 2018 | 152 | 0.370 |
Why?
| | RAW 264.7 Cells | 2 | 2024 | 49 | 0.370 |
Why?
| | Signal Transduction | 3 | 2019 | 4930 | 0.350 |
Why?
| | Surface Properties | 5 | 2019 | 393 | 0.350 |
Why?
| | Finite Element Analysis | 4 | 2024 | 72 | 0.340 |
Why?
| | Stress, Physiological | 1 | 2013 | 416 | 0.330 |
Why?
| | Insulin-Secreting Cells | 1 | 2014 | 365 | 0.320 |
Why?
| | Immunity | 1 | 2010 | 137 | 0.320 |
Why?
| | Ultraviolet Rays | 4 | 2012 | 389 | 0.320 |
Why?
| | Lactates | 1 | 2009 | 83 | 0.310 |
Why?
| | Silicones | 2 | 2024 | 22 | 0.310 |
Why?
| | Calcium | 2 | 2014 | 1189 | 0.310 |
Why?
| | Interleukin-6 | 3 | 2022 | 730 | 0.310 |
Why?
| | Elasticity | 6 | 2017 | 202 | 0.310 |
Why?
| | Norbornanes | 2 | 2019 | 14 | 0.310 |
Why?
| | Nitric Oxide | 3 | 2009 | 896 | 0.310 |
Why?
| | Models, Theoretical | 3 | 2017 | 553 | 0.310 |
Why?
| | Regenerative Medicine | 2 | 2019 | 46 | 0.300 |
Why?
| | Temporomandibular Joint | 1 | 2007 | 9 | 0.290 |
Why?
| | Mandibular Condyle | 1 | 2007 | 6 | 0.290 |
Why?
| | Fibrosis | 2 | 2022 | 529 | 0.290 |
Why?
| | Cell Line | 5 | 2017 | 2786 | 0.290 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2020 | 437 | 0.280 |
Why?
| | Humans | 26 | 2024 | 130305 | 0.280 |
Why?
| | Coculture Techniques | 2 | 2018 | 226 | 0.270 |
Why?
| | Immunity, Innate | 1 | 2012 | 814 | 0.270 |
Why?
| | Biomedical Engineering | 2 | 2004 | 25 | 0.260 |
Why?
| | Computer Simulation | 3 | 2017 | 950 | 0.260 |
Why?
| | Oxidative Stress | 1 | 2012 | 1239 | 0.250 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2020 | 255 | 0.250 |
Why?
| | Heart | 1 | 2009 | 654 | 0.240 |
Why?
| | Time Factors | 6 | 2017 | 6615 | 0.240 |
Why?
| | Particle Size | 2 | 2021 | 354 | 0.240 |
Why?
| | Myocytes, Cardiac | 1 | 2009 | 495 | 0.240 |
Why?
| | Guided Tissue Regeneration | 1 | 2004 | 13 | 0.230 |
Why?
| | Vesiculovirus | 1 | 2024 | 15 | 0.230 |
Why?
| | Peptide Fragments | 3 | 2014 | 698 | 0.220 |
Why?
| | Cell Transplantation | 1 | 2003 | 35 | 0.220 |
Why?
| | Nitrites | 1 | 2004 | 81 | 0.220 |
Why?
| | Hydrazones | 2 | 2021 | 26 | 0.220 |
Why?
| | Acrylates | 1 | 2023 | 45 | 0.210 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 132 | 0.200 |
Why?
| | Amides | 1 | 2023 | 91 | 0.200 |
Why?
| | Polystyrenes | 1 | 2022 | 38 | 0.200 |
Why?
| | Male | 15 | 2020 | 63748 | 0.200 |
Why?
| | Ink | 1 | 2022 | 10 | 0.200 |
Why?
| | Analysis of Variance | 3 | 2010 | 1291 | 0.190 |
Why?
| | Rats | 6 | 2016 | 5285 | 0.190 |
Why?
| | Muscle, Skeletal | 1 | 2012 | 1642 | 0.190 |
Why?
| | Aging | 1 | 2012 | 1785 | 0.190 |
Why?
| | Cell Line, Tumor | 3 | 2024 | 3185 | 0.190 |
Why?
| | Diffusion | 3 | 2017 | 118 | 0.180 |
Why?
| | Immunohistochemistry | 3 | 2014 | 1711 | 0.180 |
Why?
| | Thymine | 1 | 2020 | 12 | 0.180 |
Why?
| | Cell Size | 2 | 2015 | 86 | 0.180 |
Why?
| | Drug Delivery Systems | 2 | 2024 | 330 | 0.170 |
Why?
| | Receptors, Prostaglandin E, EP4 Subtype | 1 | 2020 | 5 | 0.170 |
Why?
| | Biophysics | 1 | 2020 | 69 | 0.170 |
Why?
| | Cell Proliferation | 3 | 2014 | 2381 | 0.170 |
Why?
| | Molecular Structure | 3 | 2011 | 472 | 0.170 |
Why?
| | Adsorption | 2 | 2014 | 138 | 0.170 |
Why?
| | Salter-Harris Fractures | 1 | 2019 | 11 | 0.170 |
Why?
| | Smad Proteins | 1 | 2019 | 38 | 0.170 |
Why?
| | Photosensitizing Agents | 1 | 2000 | 32 | 0.170 |
Why?
| | Culture Media | 2 | 2018 | 168 | 0.170 |
Why?
| | Collagen Type I | 2 | 2012 | 120 | 0.160 |
Why?
| | Alarmins | 1 | 2019 | 24 | 0.160 |
Why?
| | Swine | 2 | 2019 | 744 | 0.160 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 587 | 0.160 |
Why?
| | Hydrolysis | 3 | 2016 | 191 | 0.160 |
Why?
| | Hydrostatic Pressure | 1 | 2019 | 18 | 0.160 |
Why?
| | Fibrocartilage | 1 | 2019 | 5 | 0.160 |
Why?
| | Cell Shape | 2 | 2010 | 55 | 0.160 |
Why?
| | Kinetics | 3 | 2017 | 1634 | 0.160 |
Why?
| | Drug Liberation | 1 | 2019 | 29 | 0.160 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 2060 | 0.160 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2020 | 163 | 0.160 |
Why?
| | Biocatalysis | 1 | 2019 | 66 | 0.160 |
Why?
| | Muscle Contraction | 2 | 2020 | 427 | 0.150 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2854 | 0.150 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2018 | 50 | 0.150 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 166 | 0.150 |
Why?
| | Phosphorylcholine | 1 | 2018 | 18 | 0.150 |
Why?
| | Bone Substitutes | 1 | 2018 | 27 | 0.150 |
Why?
| | Equipment Design | 2 | 2017 | 526 | 0.150 |
Why?
| | DNA Primers | 2 | 2012 | 523 | 0.140 |
Why?
| | Amino Acid Motifs | 1 | 2018 | 211 | 0.140 |
Why?
| | Alkaline Phosphatase | 1 | 2018 | 149 | 0.140 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3629 | 0.140 |
Why?
| | Oligonucleotides | 1 | 2018 | 140 | 0.140 |
Why?
| | Microscopy, Confocal | 2 | 2015 | 309 | 0.140 |
Why?
| | Models, Animal | 1 | 2019 | 373 | 0.140 |
Why?
| | Injections | 1 | 2017 | 175 | 0.140 |
Why?
| | RNA, Messenger | 2 | 2020 | 2732 | 0.140 |
Why?
| | Bone Diseases | 1 | 2017 | 60 | 0.140 |
Why?
| | Shear Strength | 1 | 2016 | 68 | 0.130 |
Why?
| | Equipment Failure Analysis | 2 | 2014 | 132 | 0.130 |
Why?
| | Disease Models, Animal | 4 | 2019 | 4044 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 962 | 0.130 |
Why?
| | Female | 8 | 2020 | 68842 | 0.130 |
Why?
| | Polyesters | 2 | 2008 | 72 | 0.130 |
Why?
| | Ligands | 1 | 2018 | 624 | 0.130 |
Why?
| | Collagen Type II | 2 | 2007 | 47 | 0.130 |
Why?
| | Cell Communication | 1 | 2017 | 299 | 0.120 |
Why?
| | Cell Aggregation | 1 | 2015 | 25 | 0.120 |
Why?
| | Age Factors | 2 | 2013 | 3153 | 0.120 |
Why?
| | NIH 3T3 Cells | 2 | 2012 | 142 | 0.120 |
Why?
| | Cell Division | 3 | 2004 | 802 | 0.120 |
Why?
| | Base Sequence | 2 | 2012 | 2162 | 0.120 |
Why?
| | Models, Molecular | 1 | 2020 | 1486 | 0.120 |
Why?
| | Gene Ontology | 1 | 2014 | 49 | 0.120 |
Why?
| | Up-Regulation | 3 | 2020 | 856 | 0.120 |
Why?
| | Electrochemistry | 1 | 2014 | 81 | 0.120 |
Why?
| | Intracellular Space | 1 | 2014 | 72 | 0.120 |
Why?
| | Paracrine Communication | 1 | 2014 | 62 | 0.110 |
Why?
| | Spectrum Analysis | 1 | 2014 | 86 | 0.110 |
Why?
| | Solutions | 2 | 2014 | 148 | 0.110 |
Why?
| | Fluorescence | 1 | 2014 | 160 | 0.110 |
Why?
| | Optical Devices | 1 | 2013 | 13 | 0.110 |
Why?
| | Micromanipulation | 1 | 2013 | 14 | 0.110 |
Why?
| | Metabolism | 1 | 2013 | 39 | 0.100 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2012 | 23 | 0.100 |
Why?
| | Young Adult | 3 | 2020 | 12404 | 0.100 |
Why?
| | Rats, Inbred F344 | 2 | 2010 | 251 | 0.100 |
Why?
| | Molecular Dynamics Simulation | 1 | 2014 | 217 | 0.100 |
Why?
| | Prosthesis Design | 1 | 2014 | 322 | 0.100 |
Why?
| | Biomarkers | 3 | 2020 | 3923 | 0.100 |
Why?
| | Nanofibers | 1 | 2012 | 20 | 0.100 |
Why?
| | Apoptosis | 2 | 2012 | 2519 | 0.100 |
Why?
| | Decorin | 1 | 2011 | 6 | 0.100 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 71 | 0.090 |
Why?
| | Microscopy, Electron | 1 | 2012 | 421 | 0.090 |
Why?
| | Cells | 1 | 2011 | 24 | 0.090 |
Why?
| | Antigens, Differentiation | 1 | 2011 | 82 | 0.090 |
Why?
| | Transcription Factors | 2 | 2020 | 1649 | 0.090 |
Why?
| | Flow Cytometry | 1 | 2015 | 1158 | 0.090 |
Why?
| | Awards and Prizes | 1 | 2012 | 66 | 0.090 |
Why?
| | Polyhydroxyethyl Methacrylate | 1 | 2010 | 10 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 328 | 0.090 |
Why?
| | Nonlinear Dynamics | 1 | 2011 | 88 | 0.090 |
Why?
| | Binding Sites | 1 | 2014 | 1252 | 0.090 |
Why?
| | Temperature | 2 | 2010 | 636 | 0.090 |
Why?
| | Adult | 3 | 2018 | 35711 | 0.090 |
Why?
| | Acrylamides | 1 | 2010 | 58 | 0.090 |
Why?
| | Polymerase Chain Reaction | 2 | 2012 | 1051 | 0.090 |
Why?
| | Solubility | 1 | 2010 | 235 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 410 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2012 | 378 | 0.080 |
Why?
| | Cell Count | 1 | 2010 | 320 | 0.080 |
Why?
| | Absorption | 1 | 2009 | 57 | 0.080 |
Why?
| | Imaging, Three-Dimensional | 1 | 2013 | 563 | 0.080 |
Why?
| | Polymethacrylic Acids | 1 | 2008 | 62 | 0.080 |
Why?
| | Cell Dedifferentiation | 1 | 2008 | 30 | 0.070 |
Why?
| | Drug Compounding | 1 | 2008 | 97 | 0.070 |
Why?
| | Rabbits | 2 | 2019 | 766 | 0.070 |
Why?
| | Polymethyl Methacrylate | 1 | 2007 | 21 | 0.070 |
Why?
| | Inflammation Mediators | 1 | 2010 | 509 | 0.070 |
Why?
| | Down-Regulation | 1 | 2009 | 642 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2008 | 541 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1210 | 0.070 |
Why?
| | Animals, Newborn | 1 | 2009 | 822 | 0.070 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1018 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2012 | 744 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1714 | 0.060 |
Why?
| | Viral Envelope Proteins | 1 | 2024 | 87 | 0.050 |
Why?
| | Polyvinyl Alcohol | 2 | 2002 | 14 | 0.050 |
Why?
| | RNA | 1 | 2009 | 887 | 0.050 |
Why?
| | History, 20th Century | 1 | 2004 | 297 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2015 | 194 | 0.050 |
Why?
| | Glycoproteins | 1 | 2024 | 340 | 0.050 |
Why?
| | Cytokines | 1 | 2010 | 2016 | 0.050 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 130 | 0.050 |
Why?
| | Mice, Nude | 1 | 2003 | 688 | 0.050 |
Why?
| | Phenotype | 1 | 2010 | 3084 | 0.050 |
Why?
| | Disulfides | 1 | 2022 | 97 | 0.050 |
Why?
| | Viral Proteins | 1 | 2024 | 332 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 476 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2024 | 686 | 0.050 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2000 | 133 | 0.040 |
Why?
| | Growth Plate | 1 | 2019 | 36 | 0.040 |
Why?
| | Fibroblasts | 2 | 2008 | 953 | 0.040 |
Why?
| | Water | 2 | 2014 | 444 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2018 | 64 | 0.040 |
Why?
| | Middle Aged | 1 | 2019 | 31322 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.040 |
Why?
| | Organelles | 1 | 2018 | 55 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 185 | 0.040 |
Why?
| | Nucleic Acid Conformation | 1 | 2020 | 706 | 0.030 |
Why?
| | Endocytosis | 1 | 2018 | 163 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 398 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2000 | 1983 | 0.030 |
Why?
| | Salts | 1 | 2014 | 37 | 0.030 |
Why?
| | Sulfates | 1 | 2014 | 49 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 117 | 0.030 |
Why?
| | Gels | 1 | 2014 | 83 | 0.030 |
Why?
| | Calibration | 1 | 2014 | 137 | 0.030 |
Why?
| | Solvents | 1 | 2014 | 107 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2014 | 549 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 82 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 86 | 0.020 |
Why?
| | Biological Transport | 1 | 2012 | 397 | 0.020 |
Why?
| | Cell-Free System | 1 | 2010 | 48 | 0.020 |
Why?
| | Buffers | 1 | 2010 | 55 | 0.020 |
Why?
| | Minerals | 1 | 2010 | 39 | 0.020 |
Why?
| | Thermodynamics | 1 | 2012 | 408 | 0.020 |
Why?
| | Ceramics | 1 | 2009 | 17 | 0.020 |
Why?
| | Crystallization | 1 | 2009 | 137 | 0.020 |
Why?
| | Coated Materials, Biocompatible | 1 | 2009 | 56 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 405 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 312 | 0.020 |
Why?
| | Infant | 1 | 2017 | 9049 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 2003 | 127 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 10514 | 0.010 |
Why?
| | Somatomedins | 1 | 2002 | 28 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 20374 | 0.010 |
Why?
| | Child | 1 | 2017 | 20961 | 0.010 |
Why?
|
|
Bryant's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|